CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Open-market buy See Footnote 1 bought 17,410 shares at $2.33 ($40,546)
- 4 Open-market buy See Footnote 1 bought 104,713 shares at an average $2.32 ($242,729)
- 4 Open-market buy See Footnote 1 bought 103,984 shares at an average $2.31 ($239,778)
- 4/A Open-market buy See Footnote 1 bought 122,342 shares at $2.26 ($276,309)
- 3/A Insider 3/A
- 4 Open-market buy See Footnote 1 bought 122,342 shares at $2.26 ($276,309)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy S.V.P., General Counsel bought 50,000 shares at $2.26 ($113,210)
- 4 Open-market buy Director bought 10,000 shares at $3.19 ($31,947)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $3.23 ($32,345)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 23 · 459 filings